1. Home
  2. ATAI vs VBNK Comparison

ATAI vs VBNK Comparison

Compare ATAI & VBNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATAI
  • VBNK
  • Stock Information
  • Founded
  • ATAI 2018
  • VBNK 1980
  • Country
  • ATAI Germany
  • VBNK Canada
  • Employees
  • ATAI N/A
  • VBNK N/A
  • Industry
  • ATAI Biotechnology: Pharmaceutical Preparations
  • VBNK Commercial Banks
  • Sector
  • ATAI Health Care
  • VBNK Finance
  • Exchange
  • ATAI Nasdaq
  • VBNK Nasdaq
  • Market Cap
  • ATAI 444.7M
  • VBNK 370.1M
  • IPO Year
  • ATAI 2021
  • VBNK 2021
  • Fundamental
  • Price
  • ATAI $3.48
  • VBNK $11.75
  • Analyst Decision
  • ATAI Strong Buy
  • VBNK Strong Buy
  • Analyst Count
  • ATAI 3
  • VBNK 4
  • Target Price
  • ATAI $11.67
  • VBNK $17.50
  • AVG Volume (30 Days)
  • ATAI 8.9M
  • VBNK 35.8K
  • Earning Date
  • ATAI 08-12-2025
  • VBNK 09-04-2025
  • Dividend Yield
  • ATAI N/A
  • VBNK 0.61%
  • EPS Growth
  • ATAI N/A
  • VBNK N/A
  • EPS
  • ATAI N/A
  • VBNK 0.79
  • Revenue
  • ATAI $1,863,000.00
  • VBNK $79,960,487.00
  • Revenue This Year
  • ATAI $423.05
  • VBNK $12.97
  • Revenue Next Year
  • ATAI N/A
  • VBNK $43.72
  • P/E Ratio
  • ATAI N/A
  • VBNK $14.69
  • Revenue Growth
  • ATAI 572.56
  • VBNK N/A
  • 52 Week Low
  • ATAI $1.03
  • VBNK $8.51
  • 52 Week High
  • ATAI $4.00
  • VBNK $18.38
  • Technical
  • Relative Strength Index (RSI)
  • ATAI 60.69
  • VBNK 57.56
  • Support Level
  • ATAI $3.06
  • VBNK $11.55
  • Resistance Level
  • ATAI $3.70
  • VBNK $11.77
  • Average True Range (ATR)
  • ATAI 0.27
  • VBNK 0.16
  • MACD
  • ATAI 0.00
  • VBNK -0.00
  • Stochastic Oscillator
  • ATAI 52.46
  • VBNK 85.15

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.

About VBNK VersaBank

VersaBank is a Canadian Schedule I chartered bank with a difference. It has 3 operating segments: Digital Banking Canada, Digital Banking USA and DRTC. It's, cloud-based, business-to-business deposit and lending model provides valued-added solutions to Canadian financial intermediary partners, enabling them to focus on growing their own businesses faster and more profitably. It obtains all of its deposits and provides the majority of its loans and leases electronically, with deposit and lending solutions for financial intermediaries that allow them to excel in their core businesses. In addition, leveraging its internally developed IT security software and capabilities, Company established a wholly owned, subsidiary. Geographically located in Canada and USA.

Share on Social Networks: